The Latest in Melanoma Research: News from the Two Biggest Cancer Meetings

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 4 June 2015 In News, Science

There’s been a lot of news on melanoma treatments in the last couple of weeks coming out of the two largest cancer conferences held each year: the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) annual meetings.

Read More

Melanoma News Round-Up, June 21

21 June 2014 In News

Hello everyone!  We hope you had a wonderful week and you've been staying sun safe.  Here are a few highlights to share with you: High school students created melanoma awareness videos to warn their peers about the dangers of melanoma as part of the Jeff Dulude Melanoma Foundation & Edgemaker's...

Read More

Melanoma News Round-Up, June 14

14 June 2014 In News

Hello everyone!  Summer is in full swing and we have a fantastic video to share with you on the incredible promise of immunotherapy for melanoma treatment. [youtube url=https://www.youtube.com/watch?v=7JGn1nJNm98]And here's the latest blast of melanoma news! Tales from ASCO: Q&A with MRA's Chief Science Officer Louise Perkins via Philly.com New drugs...

Read More

Melanoma News Round-Up, May 31

31 May 2014 In News

Today is the last day of Melanoma Awareness Month and what a ride it's been!  Thank you to all of our allies and everyone who dedicated their efforts to raising awareness of melanoma and offering support to fund melanoma research.

Read More

New Melanoma Therapies Approved

31 May 2013 In News

[caption id="attachment_200" align="aligncenter" width="576"] © Ladyminnie | Dreamstime Stock Photos & Stock Free Images[/caption] These are the best types of posts to write:  On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine...

Read More

Melanoma News Round-Up May 24, 2013

24 May 2013 In News

Lots of MRA and melanoma news came out this past week; here are some highlights:

Read More